Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO Post author:Sam Post published:November 13, 2017 Post category:BioPharma Denali plans to make a $100M IPO under the symbol DNLI. Source: BioSpace You Might Also Like GlaxoSmithKline is Eyeing Pfizer's $15B+ Consumer Biz January 9, 2018 Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina February 28, 2017 BlueRock Therapeutics Sets Up HQ in Cambridge, Expands Executive Team October 25, 2017
Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina February 28, 2017
